021-51111890
购物车（）
sales@molnova.cn
ARA-290
CAS No. 1208243-50-8
ARA-290 ( Cibinetide )
产品货号. M10775 CAS No. 1208243-50-8
ARA-290 (Cibinetide) is a non-erythropoietic erythropoietin (EPO) derivative; specific agonist of erythropoietin/CD131 heteroreceptor.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥4026 | 有现货 |
|
| 10MG | ￥5856 | 有现货 |
|
| 25MG | ￥9153 | 有现货 |
|
| 50MG | ￥12312 | 有现货 |
|
| 100MG | ￥16038 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称ARA-290
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述ARA-290 (Cibinetide) is a non-erythropoietic erythropoietin (EPO) derivative; specific agonist of erythropoietin/CD131 heteroreceptor.
-
产品描述ARA-290 (Cibinetide) is a non-erythropoietic erythropoietin (EPO) derivative; specific agonist of erythropoietin/CD131 heteroreceptor; improves insulin release and glucose tolerance in type 2 diabetic GK rats.Diabetes Phase 2 Clinical
-
同义词Cibinetide
-
通路Others
-
靶点Other Targets
-
受体Other Targets
-
研究领域Metabolic Disease
-
适应症Diabetes
化学信息
-
CAS Number1208243-50-8
-
分子量1257.31
-
分子式C51H84N16O21
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 34 mg/mL
-
SMILESOC[C@@H](C(O)=O)NC([C@H](CO)NC([C@H](CC(N)=O)NC([C@H](CC(C)C)NC([C@H](C)NC([C@H](CCCNC(N)=N)NC([C@H](CCC(O)=O)NC([C@H](CC(C)C)NC([C@H](CCC(N)=O)NC([C@H](CCC(O)=O)NC([C@H](CC1)NC1=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
-
化学全称L-Serine, 5-oxo-L-prolyl-L-α-glutamyl-L-glutaminyl-L-leucyl-L-α-glutamyl-L-arginyl-L-alanyl-L-leucyl-L-asparaginyl-L-seryl-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. van Rijt WG, et al. J Transl Med. 2013 Jan 9;11:9.
2. Ahmet I, et al. Mol Med. 2011 Mar-Apr;17(3-4):194-200.
3. Muller C, et al. Mol Med. 2015 Dec 29.
2. Ahmet I, et al. Mol Med. 2011 Mar-Apr;17(3-4):194-200.
3. Muller C, et al. Mol Med. 2015 Dec 29.
产品手册
关联产品
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Fluoroethyl
Flurothyl (Indoklon) is a volatile liquid drug from the halogenated ether family.
-
Trachelogenin
Trachelogenin, an HCV entry inhibitor, has antiproliferative effects, and its mechanism is related to affecting the phosphorylation of key proteins in the β-Catenin signaling pathway, such as β-Catenin, c-Myc, and GSK3, in a concentration-dependent manner.
